Details for Patent: 10,493,124

Which drugs does patent 10,493,124 protect, and when does it expire?

Patent 10,493,124 protects GIAPREZA and is included in one NDA.

This patent has thirty-eight patent family members in twenty-two countries.

Summary for Patent: 10,493,124

Title:	Angiotensin II alone or in combination for the treatment of hypotension
Abstract:	The present invention relates, inter alia, to a method comprising administering to a subject having high output shock and undergoing treatment with a catecholamine at a dose equivalent to at least about 0.2 mcg/kg/min of norepinephrine a dose of angiotensin II which is effective to raise the blood pressure of the subject to a mean arterial pressure (MAP) of about 65 mm Hg or above, and which is effective to reduce the dose of the catecholamine required to maintain a MAP of about 65 mm Hg to the equivalent of about 0.05-0.2 mcg/kg/min norepinephrine or less, or to the equivalent of about 0.05 mcg/kg/min norepinephrine or less.
Inventor(s):	Chawla; Lakhmir S. (McLean, VA)
Assignee:	The George Washington University a Congressionally Chartered Not-for-Profit Corporation (Washington, DC)
Application Number:	15/909,617
Patent Claim Types: see list of patent claims	Use; Delivery;

Understanding the Scope and Claims of United States Patent 10,493,124: A Comprehensive Analysis

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to fully comprehend its implications and potential impact. This article will provide a detailed analysis of United States Patent 10,493,124, focusing on its claims, the technological context, and the relevant legal and procedural aspects.

Patent Overview

Patent Number and Title

United States Patent 10,493,124 is a specific patent that, like all patents, has a unique title and number. Understanding the title and the general subject matter is the first step in analyzing its scope.

Inventors and Assignees

Identifying the inventors and assignees is important as it can provide insights into the origins and ownership of the patent. This information is typically found in the patent document itself.

Filing and Grant Dates

The filing date and grant date are critical in determining the patent's priority and its term. These dates also help in understanding the patent's position within the broader timeline of technological developments.

Claims Analysis

Independent and Dependent Claims

Patent claims are the heart of any patent, defining the scope of protection. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. Analyzing both types is essential to understand the full scope of the patent[3].

Claim Construction

Claim construction involves interpreting the language of the claims to determine their meaning and scope. This process is crucial in patent litigation and can significantly impact the patent's enforceability.

Technological Context

Background of the Invention

Understanding the background of the invention, including the problems it solves and the prior art, helps in placing the patent within its technological context. This section of the patent document provides valuable insights into why the invention was necessary and how it differs from existing solutions.

Detailed Description of the Invention

The detailed description section explains how the invention works, often including drawings and examples. This part is vital for understanding the technical aspects and how the claims relate to the actual invention.

Patent Landscape

Related Patents and Applications

Using tools like the USPTO's Patent Public Search or Global Dossier, one can identify related patents and applications within the same family or those that cite the patent in question. This helps in understanding the broader patent landscape and potential overlaps or conflicts[4].

Citation Data

Analyzing citation data, such as that provided by the Common Citation Document (CCD), can reveal how the patent fits into the global patent system and how it is viewed by other patent offices.

Legal and Procedural Aspects

Patent Term Adjustment (PTA) and Terminal Disclaimers

As seen in cases like In re Cellect, patents can be subject to Patent Term Adjustment (PTA) and terminal disclaimers, which can affect their term and validity. Understanding these aspects is crucial for determining the patent's effective term and any potential limitations[1].

Obviousness-Type Double Patenting (ODP)

ODP is a critical issue that can invalidate claims if they are deemed obvious variants of earlier patents. This was a key issue in In re Cellect, where the court analyzed the network of patents and their relationships to determine validity.

Search and Analysis Tools

USPTO Resources

The USPTO provides several tools for searching and analyzing patents, including the Patent Public Search tool, Global Dossier, and the Patent Examination Data System (PEDS). These resources are essential for conducting thorough patent searches and understanding the patent's position within the broader landscape[4].

Patent Claims Research Dataset

The Patent Claims Research Dataset, maintained by the USPTO, contains detailed information on claims from US patents and applications. This dataset can be used to analyze claim-level statistics and document-level statistics, providing deeper insights into the patent's scope and impact[3].

Practical Implications

Enforcement and Litigation

Understanding the scope and claims of a patent is vital for enforcement and litigation. Misinterpreting the claims can lead to unsuccessful litigation or invalidation of the patent.

Licensing and Collaboration

For businesses considering licensing or collaborating on patented technology, a thorough analysis of the patent's scope and claims is essential. This helps in negotiating fair terms and avoiding potential legal issues.

Key Takeaways

• Claims Analysis: Independent and dependent claims define the patent's scope and are crucial for understanding its protection.
• Technological Context: The background and detailed description of the invention provide insights into its uniqueness and technical aspects.
• Patent Landscape: Analyzing related patents and citation data helps in understanding the broader patent ecosystem.
• Legal Aspects: PTA, terminal disclaimers, and ODP are critical legal considerations that can affect the patent's term and validity.
• Search Tools: Utilizing USPTO resources and datasets is essential for thorough patent analysis.

FAQs

Q: What is the importance of claim construction in patent analysis?

A: Claim construction is crucial as it determines the meaning and scope of the patent claims, which can significantly impact the patent's enforceability and validity.

Q: How do Patent Term Adjustments (PTA) affect a patent's term?

A: PTA can extend the term of a patent due to delays in the USPTO's processing, but it does not extend the term past the date of a terminal disclaimer[1].

Q: What is Obviousness-Type Double Patenting (ODP), and how does it impact patents?

A: ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of PTA. It can lead to the invalidation of claims if they are deemed obvious variants of earlier patents[1].

Q: What tools does the USPTO provide for searching and analyzing patents?

A: The USPTO offers tools such as the Patent Public Search, Global Dossier, and the Patent Examination Data System (PEDS) for thorough patent searches and analysis[4].

Q: Why is understanding the technological context of a patent important?

A: Understanding the technological context, including the background and detailed description of the invention, helps in placing the patent within its technological landscape and understanding its uniqueness and technical aspects.

Sources

1. In re Cellect, United States Court of Appeals for the Federal Circuit, August 28, 2023.
2. U.S. Patent and Trademark Office (USPTO), USAGov.
3. Patent Claims Research Dataset, USPTO.
4. Search for patents, USPTO.

Drugs Protected by US Patent 10,493,124

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
La Jolla Pharma	GIAPREZA	angiotensin ii acetate	SOLUTION;INTRAVENOUS	209360-003	Dec 23, 2021		RX	Yes	Yes						TREATING LOW BLOOD PRESSURE WITH ANGIOTENSIN II AT AN INITIAL RATE OF ABOUT 20 NG/KG/MIN AND TITRATING DOWN TO ACHIEVE AND/OR MAINTAIN A MAP OF ABOUT 65 MM HG OR ABOVE
La Jolla Pharma	GIAPREZA	angiotensin ii acetate	SOLUTION;INTRAVENOUS	209360-001	Dec 21, 2017		RX	Yes	Yes						TREATING LOW BLOOD PRESSURE WITH ANGIOTENSIN II AT AN INITIAL RATE OF ABOUT 20 NG/KG/MIN AND TITRATING DOWN TO ACHIEVE AND/OR MAINTAIN A MAP OF ABOUT 65 MM HG OR ABOVE
La Jolla Pharma	GIAPREZA	angiotensin ii acetate	SOLUTION;INTRAVENOUS	209360-002	Dec 21, 2017		DISCN	Yes	No						TREATING LOW BLOOD PRESSURE WITH ANGIOTENSIN II AT AN INITIAL RATE OF ABOUT 20 NG/KG/MIN AND TITRATING DOWN TO ACHIEVE AND/OR MAINTAIN A MAP OF ABOUT 65 MM HG OR ABOVE

International Family Members for US Patent 10,493,124

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014364528
Australia	2020277230
Australia	2024219851
Brazil	112016013961
Canada	2933601
China	106061493